Brain implant aims to forecast seizures in Drug-Resistant epilepsy
NCT ID NCT07012148
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a tiny device placed under the scalp can predict seizures in people with epilepsy that doesn't respond to medication. Twelve adults with focal epilepsy will wear the device and a smartwatch to track brain activity and other signals. The goal is to see if this approach is safe and can give early warnings, potentially helping patients manage their condition better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG REFRACTORY EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a night of soft sounds sharpen the epileptic brain?
- Brain recordings reveal how we keep tabs on others — a window into social navigation
- New brain sensor aims to stop seizures in Drug-Resistant epilepsy
- New pill aims to curb focal seizures in adults
- Virtual tours may help spare memory in epilepsy surgery
- New epilepsy drug RAP-219 enters final testing phase